CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close
Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Video

15th Annual Crock Lecture
Watch pioneering ocular gene therapy researcher Professor Jean Bennett deliver an engaging and enlightening presentation on pioneering treatments for blinding retinal disorders for the 15th annual Gerard Crock Lecture.  

Video

Next generation gene technologies
In this video, learn about how CERA’s research into gene therapies could transform the treatment of eye disease.

Consumer involvement

Help shape the future of vision research
Our new Consumer Program is working alongside people with lived experience to ensure their insights are at the heart of advancing eye research. Learn about the program and meet our Consumer Advisory Group.

Celebrating Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea will transform the delivery of ophthalmic clinical trials, increase community access to sight-saving therapies and deliver excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News
News

Professor Lauren Ayton named Member of the Order of Australia

20 February 2025

Professor Lauren Ayton has been named as a Member of the Order of Australia for her work across both vision research and advocacy.
News

First treatment for geographic atrophy approved in Australia

28 January 2025

CERA’s Head of Macular Research Professor Robyn Guymer AM has welcomed the approval of the first treatment for geographic atrophy – an advanced form of age-related macular degeneration which affects about 100,000 Australians.
News

Boost for gene therapy start-up aiming to switch on sight

23 December 2024

A gene therapy start-up aiming to regenerate damaged eye cells to switch on sight has received a major funding boost to accelerate its research to treat blindness.
Research

Research: Sleep apnoea associated with age-related macular degeneration

04 December 2024

A Centre for Eye Research Australia study has linked low levels of oxygen in the blood overnight – a common sign of obstructive sleep apnoea – with wet age-related macular degeneration.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals